Clinical trial
Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients
NCT04340661 is registered in ClinicalTrials.gov with Targeting Gut Disease S.R.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients
- Lead sponsor
- Targeting Gut Disease S.R.L.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 5, 2018
- Completion date
- January 31, 2021
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.